Koyfin Home > Directory > Health Care > Aduro Biotech > EBIT

Aduro Biotech EBIT Chart (ADRO)

Aduro Biotech annual/quarterly EBIT from 2013 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Aduro Biotech EBIT for the quarter ending June 06, 2020 was $-15m a -30.61% increase of 5m year over year
  • Aduro Biotech EBIT for the last 12 months ending June 06, 2020 was $-67m a -27.00% increase of 18m year over year
  • Aduro Biotech Annual EBIT for 2019 was $-84m a -15.97% increase of 13m from 2018
  • Aduro Biotech Annual EBIT for 2018 was $-97m a -9.33% increase of 9m from 2017
  • Aduro Biotech Annual EBIT for 2017 was $-106m a 32.49% decrease of -35m from 2016
Other Income Statement Metrics:
  • Aduro Biotech EBITDA for the quarter ending December 12, 2018 was $-23m a 9.58% decrease of -2m year over year
  • Aduro Biotech Net Income for the quarter ending December 12, 2018 was $-26m a 18.34% decrease of -5m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO EBIT Data

06/2020$-15m
03/2020$-10m
12/2019$-21m
09/2019$-20m
06/2019$-20m
03/2019$-22m
12/2018$-24m
09/2018$-25m
06/2018$-26m
03/2018$-23m

Annual ADRO EBIT Data

2019$-84m
2018$-97m
2017$-106m
2016$-72m
2015$-13m
2014$-19m
2013$-15m
2012$-10m